Cargando…
Novel plasma exosome biomarkers for prostate cancer progression in co-morbid metabolic disease
Comorbid Type 2 diabetes (T2D), a metabolic complication of obesity, associates with worse cancer outcomes for prostate, breast, head and neck, colorectal and several other solid tumors. However, the molecular mechanisms remain poorly understood. Emerging evidence shows that exosomes carry miRNAs in...
Autores principales: | Jafari, Naser, Chen, Andrew, Kolla, Manohar, Pompa, Isabella R., Qiu, Yuhan, Yu, Rebecca, Llevenes, Pablo, Ennis, Christina S., Mori, Joakin, Mahdaviani, Kiana, Halpin, Meredith, Gignac, Gretchen A., Heaphy, Christopher M., Monti, Stefano, Denis, Gerald V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836031/ https://www.ncbi.nlm.nih.gov/pubmed/36644690 http://dx.doi.org/10.1016/j.adcanc.2022.100073 |
Ejemplares similares
-
The crosstalk within the breast tumor microenvironment in type II diabetes: Implications for cancer disparities
por: Ennis, Christina S., et al.
Publicado: (2022) -
ALCOHOLISM AMONG OUTPATIENTS WITH PSYCHIATRIC MORBIDITY
por: Dhadphale, Manohar
Publicado: (1997) -
Molecular and pathological subtypes related to prostate cancer disparities and disease outcomes in African American and European American patients
por: Mori, Joakin O., et al.
Publicado: (2022) -
SGK1 inhibition induces fetal hemoglobin expression and delays polymerization in sickle erythroid cells
por: Hara, Yannis, et al.
Publicado: (2023) -
BRD4 regulates key transcription factors that drive
epithelial-mesenchymal transition in castration-resistant prostate
cancer
por: Shafran, Jordan S., et al.
Publicado: (2020)